Positive Opinions in Europe For J&J's Zytiga And Telaprevir, Pfizer's Tafamidis And Orion's Dexmedetomidine

Johnson & Johnson's Zytiga and telaprevir, as well as the first drug from Pfizer's rare disease unit and a new sedative from Swedish company Orion, were among the products granted approval by Europe's scientific advisory panel at its July meeting.